Cold atmospheric plasma for addressing the COVID-19 pandemic

Plasma Process Polym. 2022 Apr 22:e2200012. doi: 10.1002/ppap.202200012. Online ahead of print.


The coronavirus disease 2019 (COVID-19) pandemic has greatly stressed the global community, exposing vulnerabilities in the supply chains for disinfection materials, personal protective equipment, and medical resources worldwide. Disinfection methods based on cold atmospheric plasma (CAP) technologies offer an intriguing solution to many of these challenges because they are easily deployable and do not require resource-constrained consumables or reagents needed for conventional decontamination practices. CAP technologies have shown great promise for a wide range of medical applications from wound healing and cancer treatment to sterilization methods to mitigate airborne and fomite transfer of viruses. This review engages the broader community of scientists and engineers that wish to help the medical community with the ongoing COVID-19 pandemic by establishing methods to utilize broadly applicable CAP technologies.

PMID:35574246 | PMC:PMC9088580 | DOI:10.1002/ppap.202200012


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *